129 related articles for article (PubMed ID: 9464838)
1. Ectopic expression of Bcl-2, but not Bcl-xL rescues Ramos B cells from Fas-mediated apoptosis.
Alam MK; Davison S; Siddiqui N; Norton JD; Murphy JJ
Eur J Immunol; 1997 Dec; 27(12):3485-91. PubMed ID: 9464838
[TBL] [Abstract][Full Text] [Related]
2. Ligation of CD40 potentiates Fas-mediated activation of the cysteine protease CPP32, cleavage of its death substrate PARP, and apoptosis in Ramos-Burkitt lymphoma B cells.
An S; Yap D; Knox KA
Cell Immunol; 1997 Nov; 181(2):139-52. PubMed ID: 9398401
[TBL] [Abstract][Full Text] [Related]
3. Up-regulation of Bcl-xL expression protects CD40-activated human B cells from Fas-mediated apoptosis.
Zhang X; Li L; Choe J; Krajewski S; Reed JC; Thompson C; Choi YS
Cell Immunol; 1996 Oct; 173(1):149-54. PubMed ID: 8871610
[TBL] [Abstract][Full Text] [Related]
4. Distinct mechanisms for rescue from apoptosis in Ramos human B cells by signaling through CD40 and interleukin-4 receptor: role for inhibition of an early response gene, Berg36.
Ning ZQ; Norton JD; Li J; Murphy JJ
Eur J Immunol; 1996 Oct; 26(10):2356-63. PubMed ID: 8898945
[TBL] [Abstract][Full Text] [Related]
5. Bcl-x protects primary B cells against Fas-mediated apoptosis.
Schneider TJ; Grillot D; Foote LC; Núñez GE; Rothstein TL
J Immunol; 1997 Nov; 159(10):4834-9. PubMed ID: 9366408
[TBL] [Abstract][Full Text] [Related]
6. The role of bcl-XL in CD40-mediated rescue from anti-mu-induced apoptosis in WEHI-231 B lymphoma cells.
Choi MS; Boise LH; Gottschalk AR; Quintans J; Thompson CB; Klaus GG
Eur J Immunol; 1995 May; 25(5):1352-7. PubMed ID: 7539757
[TBL] [Abstract][Full Text] [Related]
7. Temporal ordering of caspase activation and substrate cleavage during antigen receptor-triggered apoptosis in Ramos-Burkitt lymphoma B cells.
An S; Park IC; Rhee CH; Hong SI; Knox K
Int J Oncol; 2003 Aug; 23(2):257-68. PubMed ID: 12851674
[TBL] [Abstract][Full Text] [Related]
8. Transforming growth factor-beta-mediated apoptosis in the Ramos B-lymphoma cell line is accompanied by caspase activation and Bcl-XL downregulation.
Saltzman A; Munro R; Searfoss G; Franks C; Jaye M; Ivashchenko Y
Exp Cell Res; 1998 Jul; 242(1):244-54. PubMed ID: 9665822
[TBL] [Abstract][Full Text] [Related]
9. Apoptosis signaling pathways in normal T cells: differential activity of Bcl-2 and IL-1beta-converting enzyme family protease inhibitors on glucocorticoid- and Fas-mediated cytotoxicity.
Moreno MB; Memon SA; Zacharchuk CM
J Immunol; 1996 Nov; 157(9):3845-9. PubMed ID: 8892614
[TBL] [Abstract][Full Text] [Related]
10. Induction of T cell clonal anergy results in resistance, whereas CD28-mediated costimulation primes for susceptibility to Fas- and Bax-mediated programmed cell death.
Boussiotis VA; Lee BJ; Freeman GJ; Gribben JG; Nadler LM
J Immunol; 1997 Oct; 159(7):3156-67. PubMed ID: 9317113
[TBL] [Abstract][Full Text] [Related]
11. Germinal center-derived signals act with Bcl-2 to decrease apoptosis and increase clonogenicity of drug-treated human B lymphoma cells.
Walker A; Taylor ST; Hickman JA; Dive C
Cancer Res; 1997 May; 57(10):1939-45. PubMed ID: 9157989
[TBL] [Abstract][Full Text] [Related]
12. Differential regulatory effects of cAMP-elevating agents on human normal and neoplastic B cell functional response following ligation of surface immunoglobulin and CD40.
Kelly K; Knox KA
Cell Immunol; 1995 Nov; 166(1):93-102. PubMed ID: 7585986
[TBL] [Abstract][Full Text] [Related]
13. G-protein signaling abnormalities mediated by CD95 in salivary epithelial cells.
Liu XB; Masago R; Kong L; Zhang BX; Masago S; Vela-Roch N; Katz MS; Yeh CK; Zhang GH; Talal N; Dang H
Cell Death Differ; 2000 Nov; 7(11):1119-26. PubMed ID: 11139286
[TBL] [Abstract][Full Text] [Related]
14. Increase in Bcl-2 level promoted by CD40 ligation correlates with inhibition of B cell apoptosis induced by vacuolar type H(+)-ATPase inhibitor.
Akifusa S; Ohguchi M; Koseki T; Nara K; Semba I; Yamato K; Okahashi N; Merino R; Núñez G; Hanada N; Takehara T; Nishihara T
Exp Cell Res; 1998 Jan; 238(1):82-9. PubMed ID: 9457059
[TBL] [Abstract][Full Text] [Related]
15. Modulation of anti-IgM-induced B cell apoptosis by Bcl-xL and CD40 in WEHI-231 cells. Dissociation from cell cycle arrest and dependence on the avidity of the antibody-IgM receptor interaction.
Merino R; Grillot DA; Simonian PL; Muthukkumar S; Fanslow WC; Bondada S; Núñez G
J Immunol; 1995 Oct; 155(8):3830-8. PubMed ID: 7561089
[TBL] [Abstract][Full Text] [Related]
16. Bcl-2 blocks glucocorticoid- but not Fas- or activation-induced apoptosis in a T cell hybridoma.
Memon SA; Moreno MB; Petrak D; Zacharchuk CM
J Immunol; 1995 Nov; 155(10):4644-52. PubMed ID: 7594463
[TBL] [Abstract][Full Text] [Related]
17. Opposing roles of CD95 (Fas/APO-1) and CD40 in the death and rescue of human low density tonsillar B cells.
Cleary AM; Fortune SM; Yellin MJ; Chess L; Lederman S
J Immunol; 1995 Oct; 155(7):3329-37. PubMed ID: 7561026
[TBL] [Abstract][Full Text] [Related]
18. Follicular dendritic cells protect malignant B cells from apoptosis induced by anti-Fas and antineoplastic agents.
Schwarz YX; Yang My; Qin D; Wu J; Jarvis WD; Grant S; Burton GF; Szakal AK; Tew JG
J Immunol; 1999 Dec; 163(12):6442-7. PubMed ID: 10586034
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of the Raf-MEK1/2-ERK1/2 signaling pathway, Bcl-xL down-regulation, and chemosensitization of non-Hodgkin's lymphoma B cells by Rituximab.
Jazirehi AR; Vega MI; Chatterjee D; Goodglick L; Bonavida B
Cancer Res; 2004 Oct; 64(19):7117-26. PubMed ID: 15466208
[TBL] [Abstract][Full Text] [Related]
20. A dual role for both CD40-ligand and TNF-alpha in controlling human B cell death.
Lens SM; Tesselaar K; den Drijver BF; van Oers MH; van Lier RA
J Immunol; 1996 Jan; 156(2):507-14. PubMed ID: 8543800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
